Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

Clinical trial NCT05766371 · RECRUITING

Trial details

NCT number: NCT05766371
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castrate Resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer Prostate Cancer Prostate Carcinoma

Start date: 2023-12-15
Primary completion: 2027-05-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.